Use of Patented Products for International Humanitarian Purposes Regulations, SOR/2005-143

Section 11

Cite as Use of Patented Products for International Humanitarian Purposes Regulations, SOR/2005-143, s. 11 · current to July 24, 2025 · regulation last amended June 25, 2018

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

For the purpose of paragraph (b) of the definition average price in subsection 21.17(6) of the Act, the publications reporting the prices in Canada of pharmaceutical products sold by or with the consent of the patentee that are equivalent to the pharmaceutical product to which an authorization under section 21.04 of the Act relates are the following: (a) the Ontario Drug Benefit Formulary/Comparative Drug Index published by the Ministry of Health and Long-Term Care of Ontario; (b) the list of insured medications set out in Schedule 1 to the Regulation respecting the List of medications covered by the basic prescription drug insurance plan, CQLR, c. A-29.01, r. 3, as is published under the title “List of Medications” on the website of the Régie de l’assurance maladie du Québec; and (c) the PPS Buyers Guide published by ProActive Pharma Solutions (PPS) or the parts of its website known as PPS Centrus where those prices are set out.
Read the Use of Patented Products for International Humanitarian Purposes Regulations on the Justice Laws Website ↗

Made under Patent Act, R.S.C. 1985, c. P-4.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.